Description |
Ilexsaponin A, isolated from the root of Ilex pubescens, attenuates ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway. Ilexsaponin A can reduce myocardial infarct size, lower the serum levels of LDH, AST and CK-MB, increase cellular viability and inhibit apoptosis in hypoxia/reoxygenation cardiomyocytes[1].
|
In Vitro |
Ilexsaponin A significantly reduces proapoptotic proteins including caspase-3, cleaved caspase-3 and bax and increases anti-apoptotic protein bcl-2 in hypoxia/reoxygenation cardiomyocytes. Ilexsaponin A treatment increases the expression levels of p-Akt in hypoxia/reoxygenation cellular model and myocardial ischemia/reperfusion animal model[1].
|
In Vivo |
Ilexsaponin A (10 or 40 mg/kg) reduce the myocardial infarct size in a dose dependent manner in male Sprague-Dawley rats weighing 280-320 g[1].
|
Density | 1.4±0.1 g/cm3 |
Boiling Point | 788.1±60.0 °C at 760 mmHg |
Flash Point | 240.1±26.4 °C |
Exact Mass | 664.382263 |
LogP | 5.11 |
Vapour Pressure | 0.0±6.2 mmHg at 25°C |
Storage condition | 2-8℃ |